Appointed
Nina Fleck
Director
MARINUS PHARMACEUTICALS, INC.
Simon Falk and Nina Fleck became the directors of the Company
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9951–10000 of 75567
Departed
Scott Braunstein
President and Chief Executive Officer
MARINUS PHARMACEUTICALS, INC.
Mr. Braunstein ceased to be President and Chief Executive Officer of the Company
Appointed
Anders Edvell
President and Chief Executive Officer
MARINUS PHARMACEUTICALS, INC.
Anders Edvell was appointed President and Chief Executive Officer of the Company
Appointed
Simon Falk
Treasurer
MARINUS PHARMACEUTICALS, INC.
Simon Falk was appointed Treasurer of the Company
Appointed
Simon Falk
Director
MARINUS PHARMACEUTICALS, INC.
Simon Falk and Nina Fleck became the directors of the Company
Appointed
Nina Fleck
Secretary
MARINUS PHARMACEUTICALS, INC.
Nina Fleck was appointed Secretary of the Company
Departed
Marvin Johnson
Director
MARINUS PHARMACEUTICALS, INC.
each of Scott Braunstein, Tim Mayleben, Elan Ezickson, Seth Fischer, Marvin Johnson, and Christine Silverstein ceased to be a director of the Company
Departed
Tim Mayleben
Director
MARINUS PHARMACEUTICALS, INC.
each of Scott Braunstein, Tim Mayleben, Elan Ezickson, Seth Fischer, Marvin Johnson, and Christine Silverstein ceased to be a director of the Company
Departed
Elan Ezickson
Director
MARINUS PHARMACEUTICALS, INC.
each of Scott Braunstein, Tim Mayleben, Elan Ezickson, Seth Fischer, Marvin Johnson, and Christine Silverstein ceased to be a director of the Company
Departed
Seth Fischer
Director
MARINUS PHARMACEUTICALS, INC.
each of Scott Braunstein, Tim Mayleben, Elan Ezickson, Seth Fischer, Marvin Johnson, and Christine Silverstein ceased to be a director of the Company
Departed
Mary Curran
Director
IIPR ·
INNOVATIVE INDUSTRIAL PROPERTIES INC
On February 7, 2025, Mary Curran informed the Company that she will retire from the Board and not stand for re-election when her term expires at the Company’s 2025 annual meeting of shareholders.
Departed
David Stecher
Director
IIPR ·
INNOVATIVE INDUSTRIAL PROPERTIES INC
David Stecher informed Innovative Industrial Properties, Inc. (the “Company”) that he will retire from the Board and not stand for re-election when his term expires at the Company’s 2025 annual meeting of shareholders.
Appointed
Mary E. Buttarazzi
Vice President, Corporate Controller and Chief Accounting Officer
IPGP ·
IPG PHOTONICS CORP
On February 7, 2025, the Board of Directors (the " Board ") of the Company appointed the Company's Vice President, Finance, Mary E. Buttarazzi, to assume the role of the Company's Vice President, Corporate Controller and Chief Accounting Officer (including its Principal Accounting Officer) effective upon Mr. Burgomaster’s retirement on March 1, 2025.
Departed
Thomas J. Burgomaster
Vice President, Corporate Controller and Chief Accounting Officer
IPGP ·
IPG PHOTONICS CORP
On February 7, 2025, Thomas J. Burgomaster, Vice President, Corporate Controller and Chief Accounting Officer (including its Principal Accounting Officer) of the Company, informed the Company of his intention to retire from his position with the Company effective March 1, 2025.
Departed
Donald F. Textor
Director
EOG ·
EOG RESOURCES INC
On February 7, 2025, Donald F. Textor informed the Board of Directors (Board) of EOG Resources, Inc. (EOG) of his decision to retire from the Board at the end of his current term and not stand for re-election as a director at EOG’s 2025 annual meeting of stockholders (2025 Annual Meeting).
Departed
Carlyn R. Taylor
Director
FLS ·
FLOWSERVE CORP
accepted the resignation of Carlyn R. Taylor from her position as a director of the Company effective immediately.
Appointed
(interim)
Matthew H. Walker
Chief Operating Officer
TRC ·
TEJON RANCH CO
appointed Matthew H. Walker, age 54, to serve as Chief Operating Officer effective March 6, 2025 through March 31, 2025
Appointed
Matthew H. Walker
President and Chief Executive Officer
TRC ·
TEJON RANCH CO
after which date Mr. Walker has been appointed and will begin serving as President and Chief Executive Officer of the Company
Departed
Gregory S. Bielli
President and Chief Executive Officer
TRC ·
TEJON RANCH CO
the previously reported retirement of Gregory S. Bielli, who has served in this capacity with the Company since December 2013.
Role change
Vineet Agarwal
Chief Financial Officer
KRRO ·
Korro Bio, Inc.
Effective February 11, 2025, Vineet Agarwal, Chief Financial Officer (principal financial officer and principal accounting officer) of Korro Bio, Inc., or Korro, is taking a temporary medical leave of absence.
Appointed
(interim)
Oliver Dolan
Interim Principal Accounting Officer
KRRO ·
Korro Bio, Inc.
and Mr. Oliver Dolan, Senior Vice President, Finance, to serve as Korro’s interim principal accounting officer
Appointed
(interim)
Ram Aiyar
Interim Principal Financial Officer
KRRO ·
Korro Bio, Inc.
Korro’s Board of Directors appointed Dr. Ram Aiyar, President and Chief Executive Officer (principal executive officer), to serve as Korro’s interim principal financial officer
Role change
Eric Schoch
Executive Vice President and President, Retail
VYX ·
NCR Voyix Corp
On February 11, 2025, NCR Voyix Corporation (the “Company”) announced the departure of Eric Schoch from his role as the Company’s Executive Vice President and President, Retail, effective immediately.
Appointed
David A. Robbie
Director
IP ·
INTERNATIONAL PAPER CO /NEW/
appointed David A. Robbie to serve as an independent director to the Board effective immediately.
Departed
Daniel Burkland
Executive Vice President, Go-to-Market Strategy
FIVN ·
Five9, Inc.
Pursuant to the Consulting Agreement, Mr. D. Burkland will transition from the role of Executive Vice President, Go-to-Market Strategy to a consultant to the Company, where he will provide transition and advisory services in the areas of sales, marketing, partnerships and customer relationships.
Appointed
Michael Ketslakh
Class II Director
BLIN ·
Bridgeline Digital, Inc.
On February 10, 2025, the Board appointed Michael Ketslakh to serve as a Class II Director of the Board, to fill the vacancy created by the resignation of Mr. Landers.
Departed
Scott Landers
Director
BLIN ·
Bridgeline Digital, Inc.
On February 5, 2025, Scott Landers announced his resignation from the Board of Directors (the “Board”) of Bridgeline Digital, Inc. (the “Company”), effective immediately.
Departed
Robert Mattacchione
Chief Executive Officer
Novo Integrated Sciences, Inc.
on February 5, 2025, the Company and Mr. Mattacchione agreed to extend the effective date of Mr. Mattacchione’s resignation to February 20, 2025
Departed
Herbert Conrad
Director
MTNB ·
Matinas BioPharma Holdings, Inc.
On February 5, 2025, Herbert Conrad informed the Board of Directors (the “ Board ”) of Matinas BioPharma Holdings, Inc. (the “ Company ”) that he was resigning from the Board effective February 6, 2025, due to retirement.
Departed
Michael R. MacDonald
Director
ULCC ·
Frontier Group Holdings, Inc.
On February 6, 2025, Michael R. MacDonald, a member of the board of directors (the “Board”) of Frontier Group Holdings, Inc. (the “Company”) since 2016, notified the Board that he will retire from the Board effective on the date of the Company’s 2025 annual meeting of stockholders.
Departed
James H. Forson
member of the Board of Directors
Invesco Real Estate Income Trust Inc.
On February 5, 2025, James H. Forson, a member of the Board of Directors ("Board") of Invesco Real Estate Income Trust Inc. (the "Company") since 2019, informed the Company that he will retire from the Board and the Audit Committee, effective June 30, 2025.
Departed
Liz O'Neill
Executive Vice President and Chief Operations Officer
LEVI ·
LEVI STRAUSS & CO
On February 11, 2025, Levi Strauss & Co. (the “Company”) announced that Liz O’Neill will retire as Executive Vice President and Chief Operations Officer on or about March 1, 2025.
Departed
James H. Forson
Director
Invesco Commercial Real Estate Finance Trust, Inc.
On February 5, 2025, James H. Forson, a member of the Board of Directors ("Board") of Invesco Commercial Real Estate Finance Trust, Inc. (the "Company") since 2023, informed the Company that he will retire from the Board and the Audit Committee, effective June 30, 2025.
Role change
Robert G. Gleeson
Chief Operating Officer
WMK ·
WEIS MARKETS INC
On February 5, 2025, the Company finalized the compensation arrangement with Mr. Gleeson, for his promotion to the role of Chief Operating Officer.
Departed
Gary L. Dake
Director
AROW ·
ARROW FINANCIAL CORP
On January 29, 2025, Gary L. Dake notified the Board of Directors of Arrow Financial Corporation (the "Company") that he will retire from the Board after serving out the rest of his term which ends at the 2025 Annual Meeting.
Appointed
Joanita Karoleski
JBS Director
PPC ·
PILGRIMS PRIDE CORP
On February 4, 2025, pursuant to the Company’s Amended and Restated Certificate of Incorporation (“Certificate of Incorporation”) and Amended and Restated Bylaws (“Bylaws”), the JBS Nominating Committee (the “JBS Nominating Committee”) of the Board of Directors (the “Board”) appointed Joanita Karoleski to the Board as a JBS Director.
Role change
Mr. Menon
JBS Director
PPC ·
PILGRIMS PRIDE CORP
In addition, Mr. Menon was re-appointed to the Board and re-classified by the JBS Nominating Committee from an Equity Director to a JBS Director.
Departed
Adam S. Umanoff
Executive Vice President, General Counsel and Corporate Secretary
EIX ·
EDISON INTERNATIONAL
Adam S. Umanoff, Executive Vice President, General Counsel and Corporate Secretary of Edison International (“EIX”) gave notice of his decision to retire from EIX, effective July 4, 2025.
Appointed
Duncan J. McKechnie
Chief Commercial Officer
VRTX ·
VERTEX PHARMACEUTICALS INC / MA
the appointment of Duncan J. McKechnie as Chief Commercial Officer of the Company
Role change
Charles F. Wagner, Jr.
Chief Operating Officer
VRTX ·
VERTEX PHARMACEUTICALS INC / MA
The Company also announced the appointment of Charles F. Wagner, Jr. as Chief Operating Officer of the Company
Departed
Stuart A. Arbuckle
Executive Vice President and Chief Operating Officer
VRTX ·
VERTEX PHARMACEUTICALS INC / MA
On February 10, 2025, Vertex Pharmaceuticals Incorporated (the “Company”) announced the retirement of Stuart A. Arbuckle, the Company’s Executive Vice President and Chief Operating Officer, effective on July 1, 2025.
Departed
Robert T. Webb
Director
NHI ·
NATIONAL HEALTH INVESTORS INC
On February 7, 2025, Robert T. Webb notified National Health Investors, Inc. (the “Company”) of his decision to resign from his position as a member of the Board of Directors (the “Board”) effective immediately.
Role change
(interim)
Richard B. Leeds
Interim Chief Executive Officer
GIC ·
GLOBAL INDUSTRIAL Co
In connection with Ms. Chaibi’s appointment, Richard B. Leeds resigned as the Company’s Interim Chief Executive Officer, effective as of the Effective Date.
Appointed
Anesa Chaibi
Director
GIC ·
GLOBAL INDUSTRIAL Co
Ms. Chaibi was also appointed to serve as a member of the Board as of the Effective Date, for a term expiring at the Company’s 2025 annual meeting of stockholders and until her successor is elected and qualified or until her earlier resignation or removal.
Appointed
Anesa Chaibi
Chief Executive Officer
GIC ·
GLOBAL INDUSTRIAL Co
On February 10, 2025, Global Industrial Company (the “Company”) announced the appointment of Anesa Chaibi as Chief Executive Officer (principal executive officer) of the Company, effective February 17, 2025 (the “Effective Date”).
Role change
Eddie Capel
Executive Vice-Chairman of the Board
MANH ·
MANHATTAN ASSOCIATES INC
Mr. Capel will assume the office of Executive Vice-Chairman of the Board.
Appointed
Eric A. Clark
Class II Board member
MANH ·
MANHATTAN ASSOCIATES INC
The Board also increased the size of the Board from eight to nine members and appointed Mr. Clark to serve as a Class II Board member.
Appointed
Eric A. Clark
President and Chief Executive Officer
MANH ·
MANHATTAN ASSOCIATES INC
the Board of Directors elected Mr. Eric A. Clark to succeed Mr. Eddie Capel as President and Chief Executive Officer of the Company, to be effective February 12, 2025.
Departed
Maria Asuncion Aramburuzabala Larregui
director
COTY ·
COTY INC.
On February 7, 2025, Maria Asuncion Aramburuzabala Larregui resigned as a director of the Board of Directors (the “Board”) of the Company after four years of service on the Board and the Remuneration and Nomination Committee.
Appointed
Kevin C. Sagara
Director
SRE ·
SEMPRA
On February 8, 2025, Sempra’s Board of Directors (the “Board”) appointed Anya Weaving, age 48, and Kevin C. Sagara, age 63, to serve on the Board.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.